News

Nearly one in four women with early-stage breast cancer who undergo a partial mastectomy will need a second surgery within 90 days.

An investigative therapy given to mice blocks the overactive immune responses that are a hallmark of inflammatory bowel disease without impairing the body's ability to fight infection.

Four faculty members are named "most influential" researchers, and other awards, honors, prizes and achievements for the week of Feb. 5 - Feb. 12.

Scientists at Weill Cornell Medicine believe immunotherapy could be the best game plan to defeat cancer.

Cell phones treated for just 10 minutes in a new desktop-sterilization device were fully rid of germs, including those that may be responsible for common skin infections.

Weill Cornell Medicine, NewYork-Presbyterian, and Houston Methodist have established a new collaborative fellowship program to create highly trained bioethicists.

Remembering hypertension expert Dr. John Laragh '48.

A subset of treatment-resistant prostate cancer pathologically resembles small cell lung cancer rather than typical prostate cancer.

Awards, honors, prizes and achievements for the week of Jan. 29 - Feb. 5.

A new investigational therapy could be a major breakthrough in the treatment of both diabetes and fatty liver.

Indigenous Arabs are direct descendants of humans who migrated out of Africa, before others continued on to colonize Europe and Asia.

Weill Cornell physician-scientists and Cornell University engineers collaborate -- and patients benefit.

For Qatari high schoolers in New York, an 'experience of a lifetime.'

Scientists have assembled the first complete genome of one of humanity's oldest and least-loved companions: the bedbug.

Edward Grab has been named the new chief operating officer of the Weill Cornell Physician Organization

Awards, honors, prizes and achievements for the week of Jan. 22 - Jan. 29.

Physicians are less likely than the general public to die in the hospital.

One of the first groups of AIDS patients to receive free HIV drugs in a public health setting in the developing world are living as long as those in the United States.

NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation's top cancer centers endorsing HPV vaccination for cancer prevention.